On May 7, the China - Indonesia Health Dialogue, themed "Caring for Women, Nurturing Hope," was successfully held in the lecture hall of Zhuhai Encode Medical Engineering Co., Ltd. Renowned experts and scholars from China and the Indonesian Fetal Maternal Medicine Association in the fields of obstetrics and gynecology, laboratory medicine, and in vitro diagnostics gathered. They engaged in in - depth discussions on topics such as advances in female urogenital ecological health and clinical diagnostics, prevention and control of bacterial vaginosis (BV), eugenics, preterm birth risk assessment, maternal - fetal health management, and precision diagnosis in maternal and child health, jointly exploring directions for international cooperation and technological innovation.
The event brought together core experts in maternal and child health and laboratory medicine from both China and Indonesia. The Chinese representatives included Dr. Tan Gongjun, M.D., chief technologist, master's supervisor, and head of the Laboratory Department at Zhuhai Maternal and Child Health Hospital (Women's and Children's Hospital). On the corporate side, Mr. Sun Yifeng, Founder and General Manager of Encode Medical; Ms. Wu Changyan, Executive Deputy General Manager of Encode Medical; and Dr. Xiong Wei, R&D Director and Technical Director of Encode Medical, attended.
The Indonesian expert team included Dr. Muhammad Alamsyah Aziz, President of the Indonesian Fetal Maternal Medicine Association; Dr. Dhanny PJ. Santoso, a maternal - fetal medicine subspecialist from the Faculty of Medicine, Padjadjaran University - Hasan Sadikin General Hospital Bandung; Dr. Mas Rizky A.A. Syamsunarno, Assistant Professor of Biomedical Sciences and Head of the Department of Basic Medical Sciences at the Faculty of Medicine, Padjadjaran University; Dr. Harya Hermawan, Obstetrics & Gynecology Resident at the Faculty of Medicine, Universitas Padjadjaran - Hasan Sadikin General Hospital Bandung; and Dr. Annisa Dewi Nugrahani, a PhD candidate in Maternal - Fetal Medicine Subtopics at the Faculty of Medicine, Universitas Padjadjaran - Hasan Sadikin General Hospital, Bandung. Among the other members of the Indonesian Fetal Maternal Medicine Association, there were those who attended the live online conference from Indonesia.
At the beginning of the event, attendees toured the Encode Medical exhibition hall, obtaining a systematic understanding of the company's technological layout and product systems in microbial diagnosis, tuberculosis diagnosis, maternal and child health testing, and infectious disease testing.
During the meeting, Mr. Sun Yifeng, Founder and General Manager of Encode, delivered a welcome speech. He noted that women's health is a vital component of the global public health system. With the rapid development of precision medicine and molecular diagnostic technologies, the IVD industry is playing an increasingly important role in gynecological infection screening, pregnancy and childbirth risk early warning, and reproductive health management. He expressed hope that this China - Indonesia Health Dialogue would further promote academic exchanges and industrial collaboration in maternal and child health diagnostics, jointly contributing to the advancement of global women's health.
In the keynote presentation session, Dr. Tan Gongjun delivered a speech on the topic "Advances in Female Urogenital Ecological Health and Clinical Diagnostics". As the head of the Laboratory Department at Zhuhai Maternal and Child Health Hospital, he combined clinical cases with laboratory medicine research findings to systematically elaborate on the relationship between the female reproductive tract microbiome and the occurrence and development of gynecological diseases. He also introduced the latest progress in the precise detection of gynecological infections and the application of biomarkers.
Dr. Dhanny PJ. Santoso shared insights based on local clinical practice experience, addressing the current situation of female reproductive tract infections in Indonesia and the needs for maternal - fetal health management.
Dr. Mas Rizky A.A. Syamsunarno, Assistant Professor of Biomedical Sciences and Head of the Department of Basic Medical Sciences at the Faculty of Medicine, Padjadjaran University, along with other Indonesian experts and scholars, also engaged in in - depth exchanges on gynecological infection screening, maternal - fetal medical management, and clinical diagnosis and treatment needs.
The attending experts unanimously agreed that strengthening early screening and diagnosis of gynecological infectious diseases is of great significance in reducing the risk of preterm birth and improving women's reproductive health.
During the corporate technology sharing session, Dr. Xiong, the R&D Director and Technical Director of Encode, highlighted the company's comprehensive solutions in the field of women's health and preterm birth diagnosis. These included the BV product series, fFN and iGFBP preterm birth risk assessment products, STD series testing products, and Group B Streptococcus testing products, fully demonstrating Encode Medical's technological innovation achievements and industrialization capabilities in the field of precise testing for women's health.
The meeting then transitioned into the exchange session. Chinese and Indonesian experts and scholars conducted warm and in - depth discussions on topics such as the standardization of gynecological infection testing, laboratory quality control, international market demands, clinical application translation, and future cooperation directions. The interactive and lively academic atmosphere further promoted consensus and mutual trust between the two sides in the field of maternal and child health.
Finally, the Indonesian expert representatives presented commemorative plaques to Chinese expert Dr. Tan Gongjun and General Manager Mr. Sun Yifeng, expressing their best wishes for the academic exchange and cooperative friendship between the two sides.
The successful hosting of the "Caring for Women, Nurturing Hope: China - Indonesia Health Dialogue" has further deepened academic exchanges and industrial collaboration between the two countries in the fields of maternal and child health and laboratory medicine. It has established a solid communication platform for the international development of precise diagnostic technologies for women's health. In the future, Encode Medical will continue to focus on the field of maternal and child health, empowering the high - quality development of global women's health with innovative IVD technologies.
